Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
NCT04833140Phase 3Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2021
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol in Nonalcoholic steatohepatitis (NASH), sponsored by Massachusetts General Hospital. Started Dec 2021; status: active, not recruiting.
02
Drugs
estradiol
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04833140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833140.